author-photo

Shweta Chhetri

Harvard University

18

Papers

656

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma

2009 Leukemia
Show All
- Source
- Cite
- Save
Citations (57)
High dose of Zoledronic acid inhibits both osteoclasts and osteoblasts in an In Vivo mouse model

2008 Bone
Show All
- Source
- Cite
- Save
Citations (0)
Clinical, Radiographic, and Biochemical Characterization of Multiple Myeloma Patients with Osteonecrosis of the Jaw

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (118)
Neutralizing B-Cell–Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model

2007 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (106)
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts

2007 Blood
Show All
- Source
- Cite
- Save
Citations (128)
In Vivo Effects of Zoledronic Acid on Bone Remodeling.

2007 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Clinical, Radiographic, and Biomarker Characterization of Multiple Myeloma Patients with Bisphosphonate Associated Osteonecrosis of the Jaw.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (0)
BIRB796 Inhibits p38 MAPK/Hsp27 Pathway and Enhances Cytotoxicity Triggered by Bortezomib, Hsp90 Inhibitor, and Dexamethasone in Multiple Myeloma.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Novel Etodolac Analog SDX-308 (CEP-18082) Induces Cytotoxicity in Multiple Myeloma Cells Associated with Inhibition of Wnt/β-Catenin Pathway.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (1)
The In Vivo Activity of Neutralizing B Cell-Activating Factor (BAFF) Antibody in the Treatment of Multiple Myeloma (MM).

2006 Blood
Show All
- Source
- Cite
- Save
Citations (1)